Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Intermediate-Risk Pulmonary Embolism

NCT02596555 is registered in ClinicalTrials.gov with Prof. Stavros Konstantinides, MD as lead sponsor.

NCT NCT02596555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02596555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for the Treatment of Acute Intermediate-Risk Pulmonary Embolism
Lead sponsor
Prof. Stavros Konstantinides, MD
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2016
Completion date
February 29, 2020
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism